A cluster-randomized trial involving 403 Australian adults aged 45–65 found that a 12-month nurse-led behavioral intervention ...
Please provide your email address to receive an email when new articles are posted on . Brain health and dementia care are getting more attention as the aging population in the U.S. rises. PCPs are ...
Newswise — CHICAGO, March 11, 2020 – A new survey of primary care physicians appearing in the Alzheimer’s Association 2020 Alzheimer’s Disease Facts and Figures report finds nearly 9 in 10 primary ...
The underdiagnosis of dementia, especially among Black and Hispanic patients, is a long-standing challenge in medicine. A new study, published in Nature Medicine, finds that an easy five-minute ...
A cluster randomised trial in Australian general practices found that a nurse-led, app-supported behavioural programme ...
A trio of studies led by Indiana University School of Medicine researchers has found that digital testing during primary care visits showed some promise as a tool for early identification of Alzheimer ...
Less than 1 in 4 primary care clinicians report using newer blood-based Alzheimer’s disease tests for patients with suspected cognitive impairment, according to research presented at the American ...
An important piece of the dissemination team’s ongoing work is to encourage payers to develop and implement dementia care management bundled payment or similar value-based payment to ensure adequate ...
Primary care physicians (PCPs) in Ontario frequently used diagnostic tools to assess patients for Alzheimer’s disease and dementia, with usage increasing during follow-up. Antidepressants were ...
A qualitative interview study of Beijing general practitioners and family caregivers identifies interrelated barriers to ...
Please provide your email address to receive an email when new articles are posted on . eRADAR examines demographics, chronic health conditions, vital signs and other data in EHRs. Patients identified ...
Participants in the Risk Assessment and Management Program-Diabetes Mellitus had reduced risks of developing all-cause dementia by 28%, Alzheimer disease by 15%, vascular dementia by 39%, and other or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results